Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 225Lymphoma, Large B-Cell, Diffuse 160Precursor Cell Lymphoblastic Leukemia-Lymphoma 143Lymphoma, Non-Hodgkin 139Hodgkin Disease 106Burkitt Lymphoma 99Lymphoma, Follicular 85Leukemia 82Lymphoma, Mantle-Cell 76Lymphoma, Large-Cell, Immunoblastic 68Leukemia, Lymphocytic, Chronic, B-Cell 56Lymphoma, B-Cell, Marginal Zone 43Leukemia, Myeloid, Acute 34Recurrence 31Lymphoma, B-Cell 31Lymphoma, Large-Cell, Anaplastic 30Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 29Dendritic Cell Sarcoma, Interdigitating 29Lymphoma, Extranodal NK-T-Cell 26Multiple Myeloma 24Waldenstrom Macroglobulinemia 22Myelodysplastic Syndromes 22Lymphoma, T-Cell, Peripheral 22Lymphoma, T-Cell, Cutaneous 20Blast Crisis 19Lymphoma, T-Cell 18Leukemia, Myeloid, Accelerated Phase 18Immunoblastic Lymphadenopathy 18Congenital Abnormalities 18Neoplasms, Plasma Cell 16

Interventions

Zidovudine 2Vincristine 2Valganciclovir 2Rituximab 2Prednisone 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tocilizumab 1tanespimycin 1liposomal doxorubicin 1ibrutinib 1deltacortene 1Sirolimus 1Polymerase Chain Reaction 1Methotrexate 1Interferon-alpha 1Hyaluronoglucosaminidase 1Histological Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1CT-P10 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multi-centric Castleman's Disease × Etoposide × Lymphoid × Clear all
NCT00092222 2026-06-01

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

NCT03864419 2024-01-03

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Fred Hutchinson Cancer Center

Phase 1 Terminated
18 enrolled
Lymphoid

Multi-centric Castleman's Disease, Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡